SOCMA-USMCA-Comments
January 31, 2019 Office of the Secretary United States International Trade Commission 500 E Street SW Washington, DC 20436 Via... View Article
January 31, 2019Latest Updates
Texas Senator Kelly Hancock to Headline Programming for Specialty & Custom Chemicals America
ARLINGTON, VA – The Society of Chemical Manufacturers & Affiliates (SOCMA) is pleased to announce that Texas Senator Kelly Hancock (R) will keynote the inaugural Specialty & Custom Chemicals America trade show, February 11-14, in Fort Worth, TX.
January 30, 2019SOCMA Applauds Bipartisan Passage of Chemical Facility Anti-Terrorism Standards Program
ARLINGTON, VA – In a major win for the specialty and fine chemical industry, the Society of Chemical Manufacturers & Affiliates (SOCMA) hails the bipartisan passage of legislation in both the House and Senate to reauthorize the Department of Homeland Security’s Chemical Facility Anti-Terrorism Standards (CFATS) program.
January 17, 2019SOCMA Comments on Negotiating Objectives for a U.S.–UK Trade Agreement
January 15, 2019 Mr. Edward Gresser Chair of the Trade Policy Staff Committee Office of the U.S. Trade Representative 600... View Article
January 15, 2019SOCMA-US-UK-FTA-Comments
January 15, 2019 Mr. Edward Gresser Chair of the Trade Policy Staff Committee Office of the U.S. Trade Representative 600... View Article
January 15, 2019Government Shutdown Impacting Generic Drug User Fee Program, other FDA Programs
After almost three weeks, the government shutdown is having a ripple affect on the Food and Drug Administration’s (FDA) submission of Generic Drug User Fee Act (GDUFA) and other pharmaceutical supply chain user fee programs overseen by the Agency.
January 11, 2019TSCA Delays Anticipated Due to Government Shutdown
With the U.S. government shutdown moving into its third week, the Environmental Protection Agency (EPA) has signaled it anticipates delays related to its responsibilities under the Toxic Substances Control Act (TSCA).
January 9, 2019SOCMA’s BPTF Executive Director Shares Perspective on API Supply Issues, Impact on PharmaChem Sector FDA Workshop addresses underlying issues related... View Article
November 29, 2018SOCMA’s BPTF Executive Director Shares Perspective on API Supply Issues, Impact on PharmaChem Sector
ARLINGTON, VA – John DiLoreto, Executive Director of the Bulk Pharmaceuticals Task Force and advisor to SOCMA’s PharmaChem Sector, delivered a fresh perspective on the pharmaceutical supply problem as a trickle-down effect of multiple factors within the fine and specialty chemical sector during a panel discussion on Manufacturing and Supply Challenges in Washington, D.C.
November 29, 2018SOCMA Comments on the U.S. Chemical Safety Board’s Call to Action on Combustible Dust
U.S. Chemical Safety Board 1750 Pennsylvania Avenue, NW Suite 910 Washington, DC 20006 combustibledust@csb.gov Re: CSB Releases Call to Action... View Article
November 20, 2018